Medived Innovations Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 25-06-2024
- Paid Up Capital ₹ 2.32 Cr
as on 25-06-2024
- Company Age 17 Year, 9 Months
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 3.00 Cr
as on 25-06-2024
- Revenue -99.17%
(FY 2018)
- Profit 39.44%
(FY 2018)
- Ebitda 67.07%
(FY 2018)
- Net Worth -68.80%
(FY 2018)
- Total Assets -51.00%
(FY 2018)
About Medived Innovations
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.32 Cr.
The company currently has active open charges totaling ₹3.00 Cr.
Dinesh Puri and Uday Puri serve as directors at the Company.
- CIN/LLPIN
U33119KA2007PTC041916
- Company No.
041916
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Feb 2007
- Date of AGM
30 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Medived Innovations Private Limited offer?
Medived Innovations Private Limited offers a wide range of products and services, including Diodes & Electronic Active Devices, Integrated Circuits, Packaging & Lamination Machinery, Vacuum Packaging Machines.
Who are the key members and board of directors at Medived Innovations?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dinesh Puri  | Director | 27-Feb-2007 | Current |
| Uday Puri | Director | 13-May-2013 | Current |
Financial Performance and Corporate Structure Insights of Medived Innovations.
Medived Innovations Private Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 99.17% decrease. The company also saw a substantial improvement in profitability, with a 39.44% increase in profit. The company's net worth observed a substantial decline by a decrease of 68.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medived Innovations?
In 2018, Medived Innovations had a promoter holding of 65.37% and a public holding of 34.63%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Department Of Biotechnology Creation Date: 16 May 2011 | ₹1.50 Cr | Open |
Department Of Biotechnology Creation Date: 16 May 2011 | ₹1.50 Cr | Open |
How Many Employees Work at Medived Innovations?
Unlock and access historical data on people associated with Medived Innovations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medived Innovations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medived Innovations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
